Table 3.
Changes in pain score, analgesic intake, and response
Treatment |
Pain scores (NRS) |
Analgesic intake
c
|
Response
d
|
||
---|---|---|---|---|---|
Baseline | Day 3 | 1 Month | |||
1a |
7 |
4 |
4 |
Stable |
PR |
1ba |
7 |
7 |
7 |
Stable |
NR |
2 |
8 |
8 |
7 |
Stable |
NR |
3 |
8 |
9 |
2 |
Stable |
PR |
4 |
6 |
6 |
7 |
Stable |
NR |
5a |
8 |
8 |
4 |
Reduction |
PR |
6 |
9 |
4 |
0 |
Increase |
PR |
7 |
4 |
2 |
5 |
Stable |
NR |
5ba |
10 |
8 |
5 |
Reduction |
PR |
8 |
9 |
7 |
0 |
Stable |
CR |
9 |
6 |
6 |
1 |
Reduction |
PR |
10b |
9 |
4 |
- |
- |
- |
11b | 7 | 7 | - | - | - |
Abbreviations: NRS numeric rating scale.
aSecond treatment in the same patient was not included in the response analysis.
bNo follow-up data available at 30 days after treatment, only included in response analysis at 3 days.
cAt 1 month after treatment compared to baseline; reduction is defined as ≥25% decrease in daily oral morphine equivalent (OMED), increase is defined as ≥25% increase in OMED, and stable is defined as neither increase nor decrease [33,34].
dResponse at 1 month as defined by the updated International Bone Metastases Consensus Working Party [33,34]. Partial response (PR): pain reduction of ≥2 or more at the treated site on a 0 to 10 scale without analgesic increase or analgesic reduction without increase in pain. Complete response (CR): pain score of 0 at the treated site with no concomitant increase in analgesics. No response (NR): no partial or complete response.